We want to thank all our amazing speakers, sponsors, and attendees who made our conference incredible - THANK YOU 👏⭐️ @Phelan_McDermid@AutismScienceFd
If you missed it, videos of each presentation will be posted later this month. Stay tuned!
Ho trascorso due giorni al Seaver Center del Mount Sinai parlando dei miei progetti di ricerca, di autismo e di disturbi del neurosviluppo.
La scienza si fa e si discute in luoghi come questi: tra ricercatori, medici e famiglie che convivono ogni giorno con queste condizioni.
Attending 30th annual Advances in Autism Conference by @SeaverAutism w/@MountSinaiNYC
Understanding genetics & genomic sciences , function based treatments , autism variants , three decades of treatment progress & testimonials
Cc
@KEMRI_Kenya@KNH_hospital@fnoluga
PRESS RELEASE | FULL STUDY OUT NOW! Researchers @IcahnMountSinai have uncovered a substantial genetic component to #PostpartumPsychosis, a rare but severe psychiatric illness that occurs in the days to weeks after childbirth. Learn More | Press Release👉 https://t.co/pK8VF5fyl9
We love when autism is in the headlines, but we hate when it's misinformation.
Join us in 3 weeks to tackle the misleading information about autism and stand confident in the facts.
🎟️: https://t.co/9SZLNsLLEj
Our team is thrilled to be presenting at the 3rd annual International DDX3X Conference in Genoa, Italy! 🇮🇹
Dr. Dorothy Grice presented clinical study advances, and Drs. @DeRubeisLab & @NanYang_NY presented preclinical and translation study updates.
What a beautiful program! 3 @icahnmountsinai students, in partnership w/ @SeaverAutism, have launched a free 12-week ballet program in NYC for children w/ #Autism, fostering improved motor skills, confidence & social connection. Learn More @CBSNewYork 👉 https://t.co/bwTord9Y9s
SYNGAP1-Related Disorders (SRD) are ultra-rare genetic disorders 🧬 caused by a variant on the SYNGAP1 gene. ~2/3 of individuals with SRD have an official autism diagnosis. Learn more about our SYNGAP1 studies on the @cureSYNGAP1 webinar
💻Register: https://t.co/gbGUvROdkA
Think about another person's feelings and intentions.
Identify emotions in others, explain why someone might feel that way (e.g., "She is mad because her juice spilled"), discuss options for response.
Plan ahead and practice! Don't forget to talk afterwards to see how the experience made your child feel - what was great, and ideas to make it even more comfortable next time.
Success is in the details! Association vs. causality, and more - learn just how important understanding the facts is for treatment and care.
Get your ticket 🎟️: https://t.co/9SZLNsLLEj
🩰Dance can help confidence, facilitate social interactions, & improve motor coordination, balance, & learning.
Watch the @CBSNewYork feature of our free Approach To Dance Autism Through Personalized Teaching (ADAPT) class, a collab with @IcahnMountSinai.
https://t.co/Es8M6Nv8Kw
The goal of the Physical Activity in Youth on the Autism Spectrum: Study 1 at the @KesslerFdn (East Hanover, NJ) is to understand and improve physical activity in youth on the spectrum.
🚶Participants: 15-24 years-old with autism diagnosis
Learn more: https://t.co/4gtMycCiX9
“There’s an infinite number of new directions that hopefully people will be interested in pursuing…there’s tons of room for promise and optimism.”
These words from Dr. Alex Kolevzon capture the spirit of the 2026 PMS Drug Development Symposium perfectly. We are so grateful for your expertise, your dedication, and your hope.
We’re building the path to therapies. Together.
@SeaverAutism
#PhelanMcDermidSyndrome #RareDisease #DrugDevelopment #ClinicalTrials #GeneticTesting
Our Clinical Director, Dr. Alex Kolevzon, has been named @CureSHANK's #InvestigatorOfTheYear 🏆at the 2026 PMS Drug Development Symposium - recognizing his tireless work characterizing natural history of Phelan-McDermid syndrome, developing biomarkers, & advancing new therapies!